BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27585736)

  • 1. Fiducial marker guided prostate radiotherapy: a review.
    O'Neill AG; Jain S; Hounsell AR; O'Sullivan JM
    Br J Radiol; 2016 Dec; 89(1068):20160296. PubMed ID: 27585736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the three degrees-of-freedom fiducial marker-based setup compared to soft tissue-based setup in hypofractionated intensity-modulated radiotherapy for prostate cancer.
    Tanabe S; Utsunomiya S; Abe E; Sato H; Ohta A; Sakai H; Yamada T; Kaidu M; Aoyama H
    J Appl Clin Med Phys; 2019 Jun; 20(6):53-59. PubMed ID: 31054217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential failure risk of the cone-beam computed tomography-based planning target volume margin definition for prostate image-guided radiotherapy based on a prospective single-institutional hybrid analysis.
    Hirose K; Sato M; Hatayama Y; Kawaguchi H; Komai F; Sohma M; Obara H; Suzuki M; Tanaka M; Fujioka I; Ichise K; Takai Y; Aoki M
    Radiat Oncol; 2018 Jun; 13(1):106. PubMed ID: 29880006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging.
    Osman SOS; Russell E; King RB; Crowther K; Jain S; McGrath C; Hounsell AR; Prise KM; McGarry CK
    Radiat Oncol; 2019 Dec; 14(1):237. PubMed ID: 31878967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of an MR-only workflow for prostate radiotherapy using semi-automatically burned-in fiducial markers.
    Goudschaal K; Beeksma F; Boon M; Bijveld M; Visser J; Hinnen K; van Kesteren Z
    Radiat Oncol; 2021 Feb; 16(1):37. PubMed ID: 33608008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy.
    Maspero M; Seevinck PR; Willems NJW; Sikkes GG; de Kogel GJ; de Boer HCJ; van der Voort van Zyp JRN; van den Berg CAT
    Radiat Oncol; 2018 Jun; 13(1):105. PubMed ID: 29871656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity-modulated radiotherapy (IMRT) to prostate and pelvic nodes-is pelvic lymph node coverage adequate with fiducial-based image-guided radiotherapy?
    Eminowicz G; Dean C; Shoffren O; Macdougall N; Wells P; Muirhead R
    Br J Radiol; 2014 May; 87(1037):20130696. PubMed ID: 24646126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-prostatic gold fiducial marker insertion for image-guided radiotherapy (IGRT): five-year experience on 795 patients.
    Mahdavi A; Mofid B; Taghizadeh-Hesary F
    BMC Med Imaging; 2023 Jun; 23(1):79. PubMed ID: 37308834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate deformation during hypofractionated radiotherapy: an analysis of implanted fiducial marker displacement.
    Knybel L; Cvek J; Blazek T; Binarova A; Parackova T; Resova K
    Radiat Oncol; 2021 Dec; 16(1):235. PubMed ID: 34876173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.
    Zelefsky MJ; Kollmeier M; Cox B; Fidaleo A; Sperling D; Pei X; Carver B; Coleman J; Lovelock M; Hunt M
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):125-9. PubMed ID: 22330997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
    Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
    Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dose escalated fiducial marker-based image guided radical radiotherapy in locally advanced prostate cancers: A single institute experience from India.
    Gupta PK; Rastogi N; Maria Das KJ; Kumar S
    J Cancer Res Ther; 2023; 19(2):382-388. PubMed ID: 37006073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers.
    Oehler C; Lang S; Dimmerling P; Bolesch C; Kloeck S; Tini A; Glanzmann C; Najafi Y; Studer G; Zwahlen DR
    Radiat Oncol; 2014 Nov; 9():229. PubMed ID: 25384898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fiducial markers implantation for prostate image-guided radiotherapy: a report on the transperineal approach.
    De Cicco L; Bracelli S
    Radiol Med; 2019 Feb; 124(2):132-135. PubMed ID: 30361924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End-to-end validation of fiducial tracking accuracy in robotic radiosurgery using MRI-only simulation imaging.
    Singhrao K; Zubair M; Nano T; Scholey JE; Descovich M
    Med Phys; 2024 Jan; 51(1):31-41. PubMed ID: 38055419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer.
    Murray J; Griffin C; Gulliford S; Syndikus I; Staffurth J; Panades M; Scrase C; Parker C; Khoo V; Dean J; Mayles H; Mayles P; Thomas S; Naismith O; Baker A; Mossop H; Cruickshank C; Hall E; Dearnaley D;
    Radiother Oncol; 2020 Jan; 142():62-71. PubMed ID: 31767473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An IGRT margin concept for pelvic lymph nodes in high-risk prostate cancer.
    Groher M; Kopp P; Drerup M; Deutschmann H; Sedlmayer F; Wolf F
    Strahlenther Onkol; 2017 Sep; 193(9):750-755. PubMed ID: 28726055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of fiducial marker visibility for MRI-only prostate radiotherapy simulation.
    Singhrao K; Ruan D; Fu J; Gao Y; Chee G; Yang Y; King C; Hu P; Kishan AU; Lewis JH
    Phys Med Biol; 2020 Feb; 65(3):035015. PubMed ID: 31881546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an automatic MR-based gold fiducial marker localisation method for MR-only prostate radiotherapy.
    Maspero M; van den Berg CAT; Zijlstra F; Sikkes GG; de Boer HCJ; Meijer GJ; Kerkmeijer LGW; Viergever MA; Lagendijk JJW; Seevinck PR
    Phys Med Biol; 2017 Oct; 62(20):7981-8002. PubMed ID: 28825917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is it essential to use fiducial markers during cone-beam CT-based radiotherapy for prostate cancer patients?
    Yildirim BA; Onal C; Dolek Y
    Jpn J Radiol; 2017 Jan; 35(1):3-9. PubMed ID: 27730453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.